Global Search

Search articles, concepts, and chapters

Invest Ophthalmol Vis SciMay 202025 citations

ABCA1 Regulates IOP by Modulating Cav1/eNOS/NO Signaling Pathway.

Hu Chunchun, Niu Liangliang, Li Liping, Song Maomao, Zhang Youjia, Lei Yuan, Chen Yuhong, Sun Xinghuai


AI Summary

ABCA1 regulates eye pressure by modulating the Cav1/eNOS/NO pathway, and its activation improved outflow facility. This mechanism presents ABCA1 as a novel therapeutic target for glaucoma.

Abstract

Purpose

This study aimed to investigate the role and pathophysiological mechanism of ATP binding cassette transporter A1 (ABCA1) in regulating the IOP and aqueous humor outflow.

Methods

ABCA1 expression was measured in trabecular meshwork samples obtained from patients with POAG and human donor eyes by Western blot. To further evaluate the functional significance of ABCA1, porcine angular aqueous plexus (AAP) cells, which are equivalent to human Schlemm's canal endothelial cells, were either treated with ABCA1 agonist GW3965 or transduced with lentivirus expressing ABCA1-shRNA. Transendothelial electrical resistance, protein expression, and nitric oxide (NO) concentration were measured. GW3965 was administered by intracameral injection. IOP and aqueous humor outflow facility were also measured.

Results

ABCA1 expression was significantly higher in the trabecular meshwork tissue of patients with POAG compared with controls. ABCA1 upregulation in angular aqueous plexus cells decreased the transendothelial electrical resistance in the angular aqueous plexus monolayers accompanied by a 0.56-fold decrease in caveolin-1 expression and a 2.85-fold and 1.17-fold increase in endothelial NO synthase expression and NO concentration, respectively (n = 3, P < 0.05). Conversely, ABCA1 downregulation increased transendothelial electrical resistance and caveolin-1 expression and decreased endothelial NO synthase expression and NO production (n = 3, P < 0.05). GW3965 decreased IOP and significantly increased conventional outflow facility (P < 0.05).

Conclusions

Regulation of aqueous humor outflow via the caveolin-1/endothelial NO synthase/NO pathway is a newly defined function of ABCA1 that is different from its traditional role in mediating cholesterol efflux. ABCA1 is a compelling, novel therapeutic candidate for the treatment of glaucoma and ocular hypertension.


MeSH Terms

ATP Binding Cassette Transporter 1AnimalsAqueous HumorBenzoatesBenzylaminesBlotting, WesternCaveolin 1Electric ImpedanceEndothelial CellsGlaucoma, Open-AngleHumansIntraocular PressureLentivirusNitric OxideNitric Oxide Synthase Type IIIRNA, Small InterferingReal-Time Polymerase Chain ReactionSignal TransductionSwineTrabecular MeshworkTrabeculectomyTransfection

Key Concepts6

ABCA1 expression was significantly higher in the trabecular meshwork tissue of patients with POAG compared with controls, as measured by Western blot.

MechanismBasic ScienceCross-sectionaln=Patients with POAG and human donor eyesCh2Ch12

ABCA1 upregulation in angular aqueous plexus cells decreased the transendothelial electrical resistance in the angular aqueous plexus monolayers, accompanied by a 0.56-fold decrease in caveolin-1 expression and a 2.85-fold and 1.17-fold increase in endothelial NO synthase expression and NO concentration, respectively (n = 3, P < 0.05).

MechanismBasic ScienceIn vitro experimentn=3 samples of porcine angular aqueous …Ch2

ABCA1 downregulation in angular aqueous plexus cells increased transendothelial electrical resistance and caveolin-1 expression and decreased endothelial NO synthase expression and NO production (n = 3, P < 0.05).

MechanismBasic ScienceIn vitro experimentn=3 samples of porcine angular aqueous …Ch2

Intracameral injection of GW3965 (ABCA1 agonist) decreased IOP and significantly increased conventional outflow facility (P < 0.05).

TreatmentBasic ScienceIn vivo experimentn=Not specified in abstract, but implie…Ch2Ch29

Regulation of aqueous humor outflow via the caveolin-1/endothelial NO synthase/NO pathway is a newly defined function of ABCA1, different from its traditional role in mediating cholesterol efflux.

MechanismBasic ScienceConclusion from experimental findingsn=Not applicableCh2

ABCA1 is a compelling, novel therapeutic candidate for the treatment of glaucoma and ocular hypertension.

TreatmentExpert OpinionConclusion from experimental findingsn=Not applicableCh29

Is this article assigned to the wrong chapter(s)? Let us know.